Dr. Vieira has a Ph.D. in Biomedical Sciences from the University Of Florida College Of Medicine. She has worked in hospitals and clinics conducting clinical research with patients, as well as in biotechnology laboratories, researching the biochemistry and molecular biology of the body at a cellular level. Additionally, she worked in the food industry with the largest food company in America. Her passion is discovering existing research on dietary and lifestyle changes that prevent, cure or improve various health conditions.
It is not uncommon for individuals suffering from mixed dementia to be diagnosed with a single form of dementia, such as Alzheimer’s disease or vascular dementia. Because of this, most physicians will base their prescribing decisions on the type of dementia that has been diagnosed. It should be noted that
Although there is not one single test available that can diagnose Alzheimer’s, researchers have discovered key biomarkers associated with this disease. However, not everyone who displays these brain markers will develop the “classic” dementia that others do. A recent study from The University of Texas Medical Branch at Galveston may
Unlike most diseases, there is not one test that can definitively diagnose Alzheimer’s disease. Although brain scans can help rule out other possible causes when abnormal symptoms develop, such as strokes or brain tumors, a single test, scan, or exam cannot detect whether or not a patient is living with
By 2050, experts believe that the number of Americans living with Alzheimer’s will reach 14 million. As research continues to focus on potential treatment options, understanding key risk factors is also critical. Of the possible risk factors, researchers have closely studied the impact of alcohol consumption. Some studies have shown that
There is no denying the importance of dialysis for patients living with potentially fatal kidney diseases. Being a life-saving treatment, this intervention allows patients to better manage their illnesses. As stated by the National Kidney Foundation, nearly 500,000 Americans currently rely on this treatment to survive. However, researchers are now